412.1 Repeated COVID-19 vaccination drives memory T and B cell responses in kidney transplant recipients: Results from a multicenter randomized controlled trial
Mr. Reshwan Malahé, Netherlands
412.2 Favourable outcomes of recipients of SARS-CoV-2 RNA positive donor organs support their safe utilisation in the post-pandemic era
Ines Ushiro-Lumb, United Kingdom
412.3 Expand the Donor Pool: Kidneys from Active and Resolved COVID-19 Donors and the Impact on Kidney Transplant Function
Prof. Tarek Alhamad, United States
412.4 Hypothermic oxygenated machine perfusion is not associated with an increased risk of infection in the recipient: A retrospective single-centre cohort study
Dr. Silvia Corcione, Italy
412.5 Outcomes of the RIVASTIM: Rapamycin randomized controlled trial of immunosuppression modification to improve vaccine responses in kidney transplant recipients